Shabnam Abtahi

Shabnam Abtahi

Auto-generated profile, based on publicly available information

Shabnam Abtahi

Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2015 in Neuroepidemiology
Verified
Journal Article
Closed access
PHPouria Heydarpour
Pouria Heydarpour
SKShayan Khoshkish
Shayan Khoshkish
SAShabnam Abtahi
Shabnam Abtahi
MMMaziar Moradi-Lakeh
Maziar Moradi-Lakeh
MSMohammad Ali Sahraian
Mohammad Ali Sahraian
Background: Multiple sclerosis (MS) is one of the most common neurological disorders and a leading cause of nontraumatic disability in young adults in many countries. Recent reports from the Middle East and North Africa have suggested a moderate to high risk of MS in these countries. Methods: A literature search was performed in August 2014 in MEDLINE, EMBASE, and IMEMR to retrieve original population-based studies on MS epidemiology in the Middle East and North African countries published between 1st January 1985 and 1st August 2014. We designed search strategies using the key words: MS, prevalence, incidence, and epidemiology. According to the inclusion criteria, 52 studies were included in this systematic review. Results: McDonald's criteria were the most widely used diagnostic criteria in the studies. Most studies were conducted in single hospital-based centers with a defined catchment area. The female/male ratio ranged from 0.8 in Oman to 4.3 in Saudi Arabia. MS prevalence ranged from 14.77/100,000 population in Kuwait (2000) to 101.4/100,000 in Turkey (2006). The overall MS prevalence in the region was 51.52/100,000. The mean age at disease onset ranged from 25.2 years in Kuwait to 32.5 years in Northeastern Iran, with an overall estimate of 28.54 years. Conclusions: Recent advances in MS registries will allow nation-wide studies and temporal comparisons between countries, provided that age- and sex-standardized estimates are available.

1 January 2017 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
AGAbbas Ghaderi
Abbas Ghaderi
SAShabnam Abtahi
Shabnam Abtahi
FDForogh Davani
Forogh Davani
ZMZahra Mojtahedi
Zahra Mojtahedi
SHSeyed Vahid Hosseini
Seyed Vahid Hosseini
ABAlimohammad Bananzadeh
Alimohammad Bananzadeh
Background: Interleukin 10 (IL-10) is considered an immune modulator cytokine, showing both antitumor and pro-tumor characteristics. Its role in the pathogenesis and progression of colorectal cancer depends on microenvironmental milieu. Materials and Methods: A case–control study with 58 newly diagnosed colorectal cancer (CRC) patients, and 30 healthy individuals was conducted to compare the serum IL-10 levels between patients and controls. Furthermore, the correlation of the cytokine levels with the pathological features and prognosis of the CRC was investigated. IL-10 levels in the sera of patients and controls were measured by Enzyme-linked immunosorbent assay. Results: Mean serum IL-10 levels were significantly lower in CRC patients than in controls (P = 0.04). CRC patients with worse prognosis at the time of diagnosis tend to have higher levels of circulating IL-10 than those with better prognosis (P = 0.008). Receiver operating characteristics curve analysis demonstrated that IL-10 levels in the sera of CRC patients can be used as a prognostic biomarker in CRC patients (area under the curve = 0.71; P = 0.01). Conclusions: Our results demonstrated a dual association of serum IL-10 levels in the initiation and progression of CRC. While lower IL-10 levels were associated with higher risk of the disease, its higher levels were associated with a poorer prognosis.

22 November 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JMJuan D. Matute
Juan D. Matute
JDJinzhi Duan
Jinzhi Duan
MFMagdalena B. Flak
Magdalena B. Flak
PGPaul Griebel
Paul Griebel
JTJose A. Tascon-Arcila
Jose A. Tascon-Arcila
RBRichard S. Blumberg
Richard S. Blumberg
Intelectin-1 (ITLN1) is a lectin secreted by intestinal epithelial cells (IECs) and upregulated in human ulcerative colitis (UC). We investigated how ITLN1 production is regulated in IECs and the biological effects of ITLN1 at the host–microbiota interface using mouse models. Our data show that ITLN1 upregulation in IECs from UC patients is a consequence of activating the unfolded protein response. Analysis of microbes coated by ITLN1 in vivo revealed a restricted subset of microorganisms, including the mucolytic bacterium Akkermansia muciniphila. Mice overexpressing intestinal ITLN1 exhibited decreased inner colonic mucus layer thickness and closer apposition of A. muciniphila to the epithelial cell surface, similar to alterations reported in UC. The changes in the inner mucus layer were microbiota and A. muciniphila dependent and associated with enhanced sensitivity to chemically induced and T cell–mediated colitis. We conclude that by determining the localization of a select group of bacteria to the mucus layer, ITLN1 modifies this critical barrier. Together, these findings may explain the impact of ITLN1 dysregulation on UC pathogenesis.

28 September 2015 in International Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
SAS. Abtahi
S. Abtahi
AFA. Farazmand
A. Farazmand
MMMahdi Mahmoudi
Mahdi Mahmoudi
AAA. Ashraf‐Ganjouei
A. Ashraf‐Ganjouei
AJA. Javinani
A. Javinani
FGF. Gharibdoost
F. Gharibdoost

1 May 2015 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
SNSeyed Reza Najafizadeh
Seyed Reza Najafizadeh
ZGZaniar Ghazizadeh
Zaniar Ghazizadeh
ANArash Aghajani Nargesi
Arash Aghajani Nargesi
MMMasoud Mahdavi
Masoud Mahdavi
SAShabnam Abtahi
Shabnam Abtahi
MNManouchehr Nakhjavani
Manouchehr Nakhjavani
Heat shock proteins (HSPs) have been repeatedly implicated in the pathogenesis of rheumatoid arthritis (RA). The authors aimed to study applicability of heat shock protein 70 (HSPA1A) serum levels as a diagnostic factor and a severity indicator in patients with RA and to quantify cut-off point that predicts status of RA with highest specificity. A total of 76 patients with RA and 36 healthy adults were studied in this case-control analysis. Patients had a higher HSPA1A level than the control group (0.78 ± 0.13 vs. 0.12 ± 0.02 ng/mL, p = 0.006), irrespective of presence of absence of rheumatoid factor or anti-citrullinated cyclic peptide. Next, diagnostic accuracy of the HSPA1A in diagnosis of RA was evaluated (area under curve 0.71; p < 0.05). HSPA1A predicted status of having RA in levels above 0.42 ng/mL with more than 90 % specificity. In addition to diagnostic value, HSPA1A can distinguish between high disease activity (1.66 ± 0.75 ng/mL) and low (0.49 ± 0.1 ng/mL), moderate (0.52 ± 0.12 ng/mL), or remission phase (0.48 ± 0.11 ng/mL). Moreover, patients in remission still had a higher HSPA1A level compared to normal subject (0.48 ± 0.11 vs. 0.12 ± 0.02 ng/mL, p < 0.05). Our results showed that serum HSPA1A could be implemented as a specific tool to facilitate diagnosis and monitoring disease activity in patients with rheumatoid arthritis.

24 May 2018 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
AGAbbas Ghaderi
Abbas Ghaderi
SAShabnam Abtahi
Shabnam Abtahi